CN108524667A - It is a kind of that there is the lutein ester composition and preparation method thereof for alleviating visual fatigue effect - Google Patents
It is a kind of that there is the lutein ester composition and preparation method thereof for alleviating visual fatigue effect Download PDFInfo
- Publication number
- CN108524667A CN108524667A CN201810506149.5A CN201810506149A CN108524667A CN 108524667 A CN108524667 A CN 108524667A CN 201810506149 A CN201810506149 A CN 201810506149A CN 108524667 A CN108524667 A CN 108524667A
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- lutein ester
- seaear
- blueberry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 title claims abstract description 69
- 230000000694 effects Effects 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 45
- 208000003464 asthenopia Diseases 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 35
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 31
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 31
- 235000021014 blueberries Nutrition 0.000 claims abstract description 31
- 239000000843 powder Substances 0.000 claims abstract description 31
- 240000000249 Morus alba Species 0.000 claims abstract description 30
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 30
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 30
- 244000062995 Cassia occidentalis Species 0.000 claims abstract description 29
- 235000001948 Cassia occidentalis Nutrition 0.000 claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract description 24
- 239000003094 microcapsule Substances 0.000 claims abstract description 20
- 241000205585 Aquilegia canadensis Species 0.000 claims description 28
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 20
- 235000013734 beta-carotene Nutrition 0.000 claims description 20
- 239000011648 beta-carotene Substances 0.000 claims description 20
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 20
- 229960002747 betacarotene Drugs 0.000 claims description 20
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 15
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- -1 D-mannital Chemical compound 0.000 claims description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 6
- 235000019359 magnesium stearate Nutrition 0.000 claims description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- 239000005913 Maltodextrin Substances 0.000 claims description 4
- 229920002774 Maltodextrin Polymers 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 229940035034 maltodextrin Drugs 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000004383 Steviol glycoside Substances 0.000 claims description 3
- 235000015165 citric acid Nutrition 0.000 claims description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 235000019411 steviol glycoside Nutrition 0.000 claims description 3
- 229930182488 steviol glycoside Natural products 0.000 claims description 3
- 150000008144 steviol glycosides Chemical class 0.000 claims description 3
- 235000019202 steviosides Nutrition 0.000 claims description 3
- 239000004575 stone Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 229940100688 oral solution Drugs 0.000 claims description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims 1
- 244000025254 Cannabis sativa Species 0.000 claims 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 claims 1
- 239000000905 isomalt Substances 0.000 claims 1
- 235000010439 isomalt Nutrition 0.000 claims 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000004438 eyesight Effects 0.000 abstract description 12
- 206010047513 Vision blurred Diseases 0.000 abstract description 6
- 206010047571 Visual impairment Diseases 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 5
- 230000002195 synergetic effect Effects 0.000 abstract description 5
- 208000029257 vision disease Diseases 0.000 abstract description 5
- 230000004393 visual impairment Effects 0.000 abstract description 5
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 3
- 241000245240 Lonicera Species 0.000 abstract 1
- 241001570521 Lonicera periclymenum Species 0.000 abstract 1
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 230000001953 sensory effect Effects 0.000 abstract 1
- 229960005375 lutein Drugs 0.000 description 13
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 13
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 13
- 230000006870 function Effects 0.000 description 11
- 235000012680 lutein Nutrition 0.000 description 11
- 239000001656 lutein Substances 0.000 description 11
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 229930014669 anthocyanidin Natural products 0.000 description 5
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 5
- 235000008758 anthocyanidins Nutrition 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 210000001525 retina Anatomy 0.000 description 5
- 244000037364 Cinnamomum aromaticum Species 0.000 description 4
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 4
- 206010064930 age-related macular degeneration Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000011812 mixed powder Substances 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 235000000832 Ayote Nutrition 0.000 description 2
- 235000006008 Brassica napus var napus Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 235000005881 Calendula officinalis Nutrition 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 241001674939 Caulanthus Species 0.000 description 2
- 240000004244 Cucurbita moschata Species 0.000 description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 description 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000007976 Ketosis Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- CFLNHFUPWNRWJA-UHFFFAOYSA-N Obtusin Chemical compound O=C1C2=CC(C)=C(O)C(OC)=C2C(=O)C2=C1C=C(OC)C(OC)=C2O CFLNHFUPWNRWJA-UHFFFAOYSA-N 0.000 description 2
- OBBJQZSMXOJMCN-UHFFFAOYSA-N Obtusin Natural products COc1cc2C=CC(=O)Oc2c3OCC(Oc13)C(=C)C OBBJQZSMXOJMCN-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 208000027073 Stargardt disease Diseases 0.000 description 2
- 240000000785 Tagetes erecta Species 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 241000219793 Trifolium Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 235000005471 carotenols Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 150000002584 ketoses Chemical class 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 2
- 235000015136 pumpkin Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 235000008210 xanthophylls Nutrition 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000201986 Cassia tora Species 0.000 description 1
- 235000014552 Cassia tora Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 102000004330 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000021921 corneal disease Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000036445 liquid secretion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- SBNFWQZLDJGRLK-UHFFFAOYSA-N phenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
It is a kind of that there is the lutein ester composition and preparation for alleviating visual fatigue effect, it is related to field of health care products, it is using lutein ester as main component, quantitative compatibility is carried out with Chinese medicines with improving eyesight effect such as black fruit fructus lycii, blueberry, Cassia occidentalis, the shell of seaear, mulberry leaf and honeysuckles, makes to generate apparent synergistic function between each raw material the effective elements of the medicine.Can be effectively relieved as caused by asthenopia eye is dry, eye is puckery, the sour swollen, blurred vision of eye even visual impairment the problems such as.The composition and preparation smell, good taste, edible safety, it is without any side effects.A kind of above-mentioned preparation method with the composition for alleviating visual fatigue effect, black fruit fructus lycii, blueberry, Cassia occidentalis, the shell of seaear, mulberry leaf and honeysuckle are respectively dried, are crushed into powder, then is mixed with Lutein ester microcapsule powder, bata-carotene.The preparation method is easy to operate, can preferably coordinate the sensory difference between each raw material, and preferably retains the active ingredient in raw material.
Description
Technical field
The present invention relates to field of health care products, in particular to a kind of lutein ester group for having and alleviating visual fatigue effect
Close object and preparation method thereof.
Background technology
Asthenopia is a kind of ophthalmology common disease, and the eye caused by it is dry, eye is puckery, under the sour swollen, blurred vision of eye even eyesight
Drop, directly affects the work and life of people.Asthenopia is mainly since people are usually to the length of computer, TV, mobile phone etc.
Phase use, eyes number of winks reduce, cause tears liquid Secretion that should reduce, while scintillation screen intense stimulus eyes and cause
's.
Natural carotenol ester is a kind of important carotenoid aliphatic ester.It is widely present in marigold flower, pumpkin,
In the plants such as wild cabbage, clover.The primary structure of lutein ester is by two six-membered carbon rings by the conjugation of a son Han ten eight carbon atoms
The long-chain of double bond is connected.In digestion process, human body can efficiently hydrolyze lutein ester and release free lutein,
Then it is rapidly absorbed into blood.Studies have shown that the lutein levels in blood and macula retinae can be improved in intake lutein ester,
And the bioavailability for the lutein that lutein ester decomposes is higher than free xanthophyll.
One important biological function of lutein is exactly to protect retina, prevents the damage of ultraviolet light.Currently, whole world hair
Existing senile macular degeneration (AMD) is the main diseases causing blindness of over-65s crowd.After lutein ester is taken in body,
Under the action of body fat enzyme, it is hydrolyzed into the lutein of free state, they are deposited on high concentration in people's fundus flavimaculatus, can be used as
The absorbent of near ultraviolet blue light, by capture free radical, prevent or reduces aoxidize and free radical retina is brought injury by
Defencive function is exercised, the incidence of AMD can be effectively reduced.Supplement lutein can also promote the lymphocyte of antigenic stimulus to increase
Reaction is grown, and the functional expression of cell surface molecule can be influenced, enhances immunization.On May 26th, 2008 ministry of Health of China
Publication bulletin approval lutein ester will become one kind as new resource food, using lutein ester as the exploitation of functional food raw material
Development trend.
Invention content
The purpose of the present invention is to provide a kind of lutein ester composition and preparation for having and alleviating visual fatigue effect, energy
Enough be effectively relieved as caused by asthenopia eye is dry, eye is puckery, the sour swollen, blurred vision of eye even visual impairment the problems such as.
Another object of the present invention is to provide a kind of above-mentioned lutein ester compositions with alleviation visual fatigue effect
Preparation method, preparation method is simple, easily operated, can preferably retain the active ingredient in raw material.
What the embodiment of the present invention was realized in：
A kind of to have the lutein ester composition for alleviating visual fatigue effect, in parts by weight, raw material includes：
10~20 parts of Lutein ester microcapsule powder, 5~10 parts of black fruit fructus lycii, 20~30 parts of blueberry, beta carotene 0.1~0.5
Part, 1~3 part of Cassia occidentalis, 2~4 parts of the shell of seaear, 1~3 part of mulberry leaf and 1~3 part of honeysuckle.
A kind of above-mentioned preparation method with the lutein ester composition for alleviating visual fatigue effect comprising：
Black fruit fructus lycii, blueberry, Cassia occidentalis, the shell of seaear, mulberry leaf and honeysuckle are respectively dried, are crushed into powder, then is yellow with leaf
Plain ester micro capsule powder, beta carotene are mixed.
It is a kind of that there is the preparation for alleviating visual fatigue effect comprising acceptable auxiliary material on above-mentioned composition and food；
Preferably, auxiliary material includes microcrystalline cellulose, maltodextrin, D-sorbite, xylitol, D-mannital, antierythrite, different malt
At least one of ketose alcohol, lactose, magnesium stearate, steviol glycoside or citric acid.
The advantageous effect of the embodiment of the present invention is：
An embodiment of the present invention provides it is a kind of have alleviate visual fatigue effect lutein ester composition and preparation, with
Lutein ester has improving eyesight effect as main component, with black fruit fructus lycii, blueberry, Cassia occidentalis, the shell of seaear, mulberry leaf and honeysuckle etc.
Chinese medicine carry out quantitative compatibility, make to generate apparent synergistic function between each raw material the effective elements of the medicine.Can effectively it delay
Solution eye as caused by asthenopia is dry, eye is puckery, the sour swollen, blurred vision of eye even visual impairment the problems such as.The composition and system
Agent smell, good taste, edible safety, it is without any side effects.
The embodiment of the present invention additionally provides a kind of above-mentioned preparation with the lutein ester composition for alleviating visual fatigue effect
Black fruit fructus lycii, blueberry, Cassia occidentalis, the shell of seaear, mulberry leaf and honeysuckle are respectively dried, are crushed into powder by method, then with lutein ester
Microcapsule powder, beta carotene are mixed.The preparation method is easy to operate, can preferably coordinate the poor taste between each raw material
It is different, and preferably retain the active ingredient in raw material.
Specific implementation mode
It in order to make the object, technical scheme and advantages of the embodiment of the invention clearer, below will be in the embodiment of the present invention
Technical solution be clearly and completely described.The person that is not specified actual conditions in embodiment, builds according to normal condition or manufacturer
The condition of view carries out.Reagents or instruments used without specified manufacturer is the conventional production that can be obtained by commercially available purchase
Product.
There is the lutein ester composition for alleviating visual fatigue effect and its preparation side to a kind of of the embodiment of the present invention below
Method is specifically described.
An embodiment of the present invention provides a kind of lutein ester compositions for having and alleviating visual fatigue effect, according to parts by weight
Meter, raw material include：
10~20 parts of Lutein ester microcapsule powder, 5~10 parts of black fruit fructus lycii, 20~30 parts of blueberry, beta carotene 0.1~0.5
Part, 1~3 part of Cassia occidentalis, 2~4 parts of the shell of seaear, 1~3 part of mulberry leaf and 1~3 part of honeysuckle.
Optionally, in parts by weight, raw material includes：
10~15 parts of Lutein ester microcapsule powder, 5~8 parts of black fruit fructus lycii, 20~25 parts of blueberry, beta carotene 0.3~0.5
Part, 1~2 part of Cassia occidentalis, 2~3 parts of the shell of seaear, 1~2 part of mulberry leaf and 1~2 part of honeysuckle.
Optionally, in parts by weight, raw material includes：
10 parts of Lutein ester microcapsule powder, 5 parts of black fruit fructus lycii, 20 parts of blueberry, 0.5 part of beta carotene, 2 parts of Cassia occidentalis, Shi Jue
1 part of bright 3 parts, 2 parts of mulberry leaf and honeysuckle.
Natural carotenol ester is a kind of important carotenoid aliphatic ester.It is widely present in marigold flower, pumpkin,
In the plants such as wild cabbage, clover.The primary structure of lutein ester is by two six-membered carbon rings by the conjugation of a son Han ten eight carbon atoms
The long-chain of double bond is connected.In digestion process, human body can efficiently hydrolyze lutein ester and release free lutein,
Then it is rapidly absorbed into blood.Studies have shown that the lutein levels in blood and macula retinae can be improved in intake lutein ester,
And the bioavailability for the lutein that lutein ester decomposes is higher than free xanthophyll.One important life of lutein
Object function is exactly to protect retina, prevents the damage of ultraviolet light.After lutein ester is taken in body, in body fat enzyme
Under effect, it is hydrolyzed into the lutein of free state, they are deposited on high concentration in people's fundus flavimaculatus, can be used as near ultraviolet blue light
Absorbent, by capture free radical, prevent or reduces aoxidize and free radical retina is brought injury by exercise defencive function,
The incidence of AMD can effectively be reduced.
Black fruit fructus lycii is the ripening fruits of the more quil shrub black fruit fructus lyciis of Solanaceae Lycium, is rich in anthocyanidin, anthocyanidin
Content reaches 3690mg/100g considerably beyond blueberry.Studies have shown that anthocyanidin can promote in retina cell visual purple again
Growth, long-term consumption can have the function of significantly protecting eyesight have good health-care effect for visual fatigue.Except this with
Outside, modern research shows that black fruit fructus lycii powder pharmacological activity further relates to the following aspects：(1) hypoglycemic, antifatigue, raising body
Immunity；(2) anti-oxidant, removing free radical, oxidation resistance is 50 times of vitamin E；(3) have to tumour and cancer
There are certain prevention and resistant function.
Blueberry contains anthocyanidin, and anthocyanidin is natural potent polyphenoils, anti-eye strain, prevent cranial nerve aging,
Anticancer softening blood vessel, enhances human immunity, has the function of the good internal inflammation of elimination.It can promote impaired collagen egg
White connection, enhancing skin elasticity；Strength removal free radical, avoids peroxide from damaging skin bottom cell, prevents wrinkle and color
Spot is formed.
Beta carotene is a kind of natural carotenoid being widely present in green and yellow vegetable, fruit.β-carrot
After element intake human digestive organ, vitamin A can be converted to.Vitamin A is the photoactive substance for constituting retinal surface, when long
Between stare at computer screen and can consume a large amount of vitamin As.Except prevent yctalopia, xerophthalmia, ulcer of the cornea disease, prevention cataract with
Outside, beta carotene also has the effects that anti-oxidant, removing toxic substances, anticancer, prevention of cardiovascular disease and protection liver.
Cassia occidentalis, also known as cassia seed, nature and flavor are sweet, bitter, salty, be slightly cold.Return liver, large intestine channel.Cassia seed is containing rheum emodin, rheum officinale
Phenol, Physcion, obtusin, obtusin and its glucoside and multivitamin and abundant amino acid, fat, carbon aquation
Close object etc..Cassia seed has clearing away the liver-fire, wind-damp dispelling, tonifying kidney and improving eyesight and other effects, and cassia-tora tea can also clear liver and improve vision, prevent eyesight
It obscures, to lowering blood pressure and blood fat, reduction cholesterol, prevention and treatment of coronary heart disease, high blood pressure have good curative effect：Cassia seed is rich in
Vitamin A and zinc can prevent yctalopia and avoid zinc deficiency in children.
Shell of seaear nature and flavor are micro- salty, are slightly cold.Return liver, lung channel.Shell of seaear calcium carbonate, also containing organic matter and a small amount of magnesium, iron,
The iodine of silicate, sulfate, phosphate, chloride and denier.Shell of seaear clearing liver checking exuberance of yang, removing nebula for improving eyesight；Energy removing heat from the liver, tonifying liver
The moon, the diseases such as dizziness, twitch, cataract, glaucoma night blindness that can be used for caused by the only high or yin deficiency yang hyperactivity of liver-yang, and energy clearind deficient heat,
Have and controls low-heat of pulmonary tuberculosis and other effects.
Mulberry leaf nature and flavor are sweet, bitter, tremble with fear.Channel tropism return lung, Liver Channel.Major function dispelling wind and heat from the body, clearing away the lungheat and moisturizing are clear liver and improved vision.It can
For treating anemopyretic cold, lung-heat type cough, dizziness headache, the symptoms such as hot eyes is dim-sighted.
Honeysuckle nature and flavor are sweet, tremble with fear.Return lung, the heart, stomach.With heat-clearing improving eyesight, the effect of wind-heat dissipating, strengthen immunity.
It can be used for carbuncle swells and treat sore, larynx numbness, erysipelas, toxic-heat and blood stasis, anemopyretic cold, the symptoms such as warm disease heating.
Above-mentioned medicinal material is based on sweet taste, and mouthfeel is coordinated after mixing, smell, good taste.Meanwhile above-mentioned medicinal material
Preferable function of improving eyesight is all had, is used cooperatively down, can be synergistic, it is effectively relieved that the eye as caused by asthenopia is dry, eye
The problems such as puckery, sour swollen, blurred vision of eye or even visual impairment.
Required preparation can be made in above-mentioned composition with acceptable auxiliary material on food, and the dosage form of preparation is granule, powder
Any one in agent, capsule, tablet or oral solution.
Auxiliary material includes microcrystalline cellulose, maltodextrin, D-sorbite, xylitol, D-mannital, antierythrite, different wheat
At least one of bud ketose alcohol, lactose, magnesium stearate, steviol glycoside or citric acid.
Preferably, in parts by weight, said preparation includes：
10~20 parts of Lutein ester microcapsule powder, 5~10 parts of black fruit fructus lycii, 20~30 parts of blueberry, beta carotene 0.1~0.5
Part, 1~3 part of Cassia occidentalis, 2~4 parts of the shell of seaear, 1~3 part of mulberry leaf, 1~3 part of honeysuckle, 10~20 parts of microcrystalline cellulose, lactose
0.1~1 part of 20~30 parts, 10~20 parts of xylitol, 10~20 parts of D-mannital and magnesium stearate.Said preparation is tablet.
The embodiment of the present invention additionally provides a kind of above-mentioned preparation with the lutein ester composition for alleviating visual fatigue effect
Method comprising：
Black fruit fructus lycii, blueberry, Cassia occidentalis, the shell of seaear, mulberry leaf and honeysuckle are respectively dried, are crushed into powder, then is yellow with leaf
Plain ester micro capsule powder, beta carotene are mixed.
Wherein, the temperature dried to black fruit fructus lycii, blueberry, Cassia occidentalis, the shell of seaear, mulberry leaf and honeysuckle is 100~
130℃.The effect of drying is the moisture removed in above-mentioned raw materials, and above-mentioned raw materials is allow to be preserved for a long time.The temperature of drying
Degree is unsuitable excessively high, on the one hand needs to avoid high temperature that raw material is made to be charred influence mouthfeel, on the other hand to avoid high temperature to nutritional ingredient
Destruction.
Further, after black fruit fructus lycii, blueberry, Cassia occidentalis, the shell of seaear, mulberry leaf and the honeysuckle after drying being crushed, mistake
110~130 mesh sieve, and extracting screen underflow is mixed.Above-mentioned raw materials are pulverized and sieved can more fully between can making each component
Mixing, reach preferably synergistic function.
Stone is clear and decided once to soak 1~3h in preliminary crushing and after cleaning, and continues 0.5~1h of boiling after boiling and goes
Except decoction liquor, then secondary plus water, 0.5~1h is boiled, goes after decoction liquor to be dried again, crush.Clear and decided stone is Bao Ke animals
Shell, quality is hard, needs first to carry out preliminary crushing well-done, well-done, could preferably carry out following process.
By black fruit fructus lycii, blueberry, Cassia occidentalis, the shell of seaear, mulberry leaf and the powder of the honeysuckle frying 10 after crushing~
20min.It after above-mentioned raw materials powder frying, can not only make it well-done in advance, be conducive to eat, while can tart up, change
Kind mouthfeel.The temperature of frying is unsuitable excessively high, and medicinal ingredient is avoided to be destroyed.
The feature and performance of the present invention are described in further detail with reference to embodiments.
Embodiment 1
A kind of preparation for having and alleviating visual fatigue effect is present embodiments provided, said preparation is pulvis, and raw material includes：
Lutein ester microcapsule powder 100g, black fruit fructus lycii 50g, blueberry 300g, beta carotene 5g, Cassia occidentalis 10g, the shell of seaear
20g, mulberry leaf 30g and honeysuckle 30g.
Preparation method includes：
(1) it dried after black fruit fructus lycii, blueberry, Cassia occidentalis, mulberry leaf, honeysuckle being taken impurity, cleaned, crushed 110 mesh sieve,
It is spare.
(2) shell of seaear is placed in container, one decocts plus water crosses 4~8cm of material face, steeps 2h, with boiling with stirring, water is opened
Decoction liquor is poured out after 60min, two decoct added water 4~8cm of material face, with boiling with stirring, water falls decoction liquor after opening 45min
Go out, filter is net, and filter residue is spare.
(3) by each material after crushing in (1) together with the filter residue in (2) 10~20min of frying, fry stir well it is even after,
130 mesh sieve is crushed, mixed-powder is obtained.
(4) it is uniformly mixed with Lutein ester microcapsule powder and beta carotene after the mixed-powder in (3) dries in the air to room temperature.
Embodiment 2
A kind of preparation for having and alleviating visual fatigue effect is present embodiments provided, said preparation is pulvis comprising：
Lutein ester microcapsule powder 200g, black fruit fructus lycii 100g, blueberry 200g, beta carotene 1g, Cassia occidentalis 30g, the shell of seaear
40g, mulberry leaf 10g and honeysuckle 10g.
Preparation method is with reference to shown in embodiment 1.
Embodiment 3
A kind of preparation for having and alleviating visual fatigue effect is present embodiments provided, said preparation is tablet comprising：
Lutein ester microcapsule powder 150g, black fruit fructus lycii 70g, blueberry 250g, beta carotene 3g, Cassia occidentalis 20g, the shell of seaear
30g, mulberry leaf 20g, honeysuckle 20g, microcrystalline cellulose 100g, lactose 300g, xylitol 100g, D-mannital 200g and
Magnesium stearate 1g.
Preparation method includes：
(1) it dried after black fruit fructus lycii, blueberry, Cassia occidentalis, mulberry leaf, honeysuckle being removed impurity, cleaned, crushed 110 mesh
Sieve, it is spare.
(2) shell of seaear is placed in container, one decocts plus water crosses 4~8cm of material face, steeps 2h, with boiling with stirring, water is opened
Decoction liquor is poured out after 60min, two decoct added water 4~8cm of material face, with boiling with stirring, water falls decoction liquor after opening 45min
Go out, filter is net, and filter residue is spare.
(3) by each material after crushing in (1) together with the filter residue in (2) 10~20min of frying, fry stir well it is even after,
130 mesh sieve is crushed, mixed-powder is obtained.
(4) it is mixed with Lutein ester microcapsule powder, beta carotene and auxiliary material after the mixed-powder in (3) dries in the air to room temperature
It is tabletted after uniformly.
Embodiment 4
A kind of preparation for having and alleviating visual fatigue effect is present embodiments provided, said preparation is tablet comprising：
Lutein ester microcapsule powder 100g, black fruit fructus lycii 50g, blueberry 200g, beta carotene 5g, Cassia occidentalis 20g, the shell of seaear
30g, mulberry leaf 20g, honeysuckle 10g, microcrystalline cellulose 200g, maltodextrin 200g, D-sorbite 200g and magnesium stearate
10g。
Preparation method is with reference to shown in embodiment 3.
Test example
Select Examples 1 to 4 provided have alleviate visual fatigue effect lutein ester composition, Beijing, Shanghai,
Random sampling is done in Guangzhou, Shenzhen, Chengdu and 6, Chongqing place, alleviates visual fatigue effect for having for each embodiment
Lutein ester composition select 20 users in each place and test and track interview.Experiment 3 months by a definite date, 3
After the moon is full, questionnaire survey is carried out to every user, for the functional food in taste mouthfeel, convenient degree, therapeutic effect
Three aspects score, and full marks 10 divide, and user gives according to actual conditions to be divided, and to the functional food of each embodiment
Amount to the number that 120 users are given to average, result of calculation is as shown in table 1.
What 1 Examples 1 to 4 of table was provided has the lutein ester composition effect for alleviating visual fatigue effect
Fruit scores
As it can be seen from table 1 the lutein ester group with alleviation visual fatigue effect that the embodiment of the present invention 1~4 is provided
Object is closed in terms of therapeutic effect, client's Basic Authorization remission effect to asthenopia of the product, average mark 9.1 or so.Together
When, client also gives very high evaluation in terms of taste mouthfeel and convenient degree, and especially tablet (embodiment 3,4) is in taste
Evaluation in road mouthfeel and portable degree has reached 9.5 or so.
In conclusion an embodiment of the present invention provides it is a kind of have alleviate visual fatigue effect lutein ester composition and
Preparation, using lutein ester as main component, with the tools such as black fruit fructus lycii, blueberry, Cassia occidentalis, the shell of seaear, mulberry leaf and honeysuckle
There is the Chinese medicine of improving eyesight effect to carry out quantitative compatibility, makes to generate apparent synergistic function between each raw material the effective elements of the medicine.
Can be effectively relieved as caused by asthenopia eye is dry, eye is puckery, the sour swollen, blurred vision of eye even visual impairment the problems such as.The group
Object and preparation smell, good taste, edible safety are closed, it is without any side effects.
The embodiment of the present invention additionally provides a kind of above-mentioned preparation with the lutein ester composition for alleviating visual fatigue effect
Black fruit fructus lycii, blueberry, Cassia occidentalis, the shell of seaear, mulberry leaf and honeysuckle are respectively dried, are crushed into powder by method, then with lutein ester
Microcapsule powder, beta carotene are mixed.The preparation method is easy to operate, can preferably coordinate the poor taste between each raw material
It is different, and preferably retain the active ingredient in raw material.
The foregoing is only a preferred embodiment of the present invention, is not intended to restrict the invention, for the skill of this field
For art personnel, the invention may be variously modified and varied.All within the spirits and principles of the present invention, any made by repair
Change, equivalent replacement, improvement etc., should all be included in the protection scope of the present invention.
Claims (10)
1. a kind of having the lutein ester composition for alleviating visual fatigue effect, which is characterized in that in parts by weight, raw material
Including：
10~20 parts of Lutein ester microcapsule powder, 5~10 parts of black fruit fructus lycii, 20~30 parts of blueberry, 0.1~0.5 part of beta carotene,
1~3 part of 1~3 part of Cassia occidentalis, 2~4 parts of the shell of seaear, 1~3 part of mulberry leaf and honeysuckle.
2. according to claim 1 have the lutein ester composition for alleviating visual fatigue effect, which is characterized in that according to weight
Number meter is measured, raw material includes：
10~15 parts of the Lutein ester microcapsule powder, 5~8 parts of the black fruit fructus lycii, 20~25 parts of the blueberry, the β-Hu Luo
0.3~0.5 part of Bu Su, 1~2 part of the Cassia occidentalis, 2~3 parts of the shell of seaear, 1~2 part of the mulberry leaf and the honeysuckle
1~2 part.
3. according to claim 3 have the lutein ester composition for alleviating visual fatigue effect, which is characterized in that according to weight
Number meter is measured, raw material includes：
10 parts of the Lutein ester microcapsule powder, 5 parts of the black fruit fructus lycii, 20 parts of the blueberry, 0.5 part of the beta carotene, institute
State 1 part of 2 parts of Cassia occidentalis, 3 parts of the shell of seaear, 2 parts of the mulberry leaf and the honeysuckle.
4. a kind of preparation such as claims 1 to 3 any one of them with the lutein ester composition for alleviating visual fatigue effect
Method, which is characterized in that including：
The black fruit fructus lycii, the blueberry, the Cassia occidentalis, the shell of seaear, the mulberry leaf and the honeysuckle are dried respectively
It does, be crushed into powder, then mixed with the Lutein ester microcapsule powder, the beta carotene.
5. preparation method according to claim 4, which is characterized in that determine to the black fruit fructus lycii, the blueberry, the grass
The temperature that bright, the described shell of seaear, the mulberry leaf and the honeysuckle are dried is 100~130 DEG C.
6. preparation method according to claim 5, which is characterized in that by after drying the black fruit fructus lycii, the blueberry,
After the Cassia occidentalis, the shell of seaear, the mulberry leaf and the honeysuckle crush, 110~130 mesh sieve is crossed, extracting screen underflow carries out
Mixing.
7. preparation method according to claim 6, which is characterized in that the stone it is clear and decided preliminary crushing and clean after,
1~3h once is soaked, continues 0.5~1h of boiling after boiling and removes decoction liquor, then secondary plus water, boil 0.5~1h, go to decoct
It dried, crushed again after boil liquid.
8. preparation method according to claim 7, which is characterized in that by after crushing the black fruit fructus lycii, the blueberry,
The Cassia occidentalis, 10~20min of the shell of seaear, the mulberry leaf and the powder frying of the honeysuckle.
9. a kind of having the preparation for alleviating visual fatigue effect, which is characterized in that it includes as described in any one of claims 1 to 3
Composition and food in acceptable auxiliary material；Preferably, the auxiliary material includes microcrystalline cellulose, maltodextrin, sorbose
In alcohol, xylitol, D-mannital, antierythrite, isomalt, lactose, magnesium stearate, steviol glycoside or citric acid
It is at least one.
10. preparation according to claim 9, which is characterized in that the dosage form of the preparation be granule, pulvis, capsule,
Any one in tablet or oral solution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810506149.5A CN108524667A (en) | 2018-05-23 | 2018-05-23 | It is a kind of that there is the lutein ester composition and preparation method thereof for alleviating visual fatigue effect |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810506149.5A CN108524667A (en) | 2018-05-23 | 2018-05-23 | It is a kind of that there is the lutein ester composition and preparation method thereof for alleviating visual fatigue effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108524667A true CN108524667A (en) | 2018-09-14 |
Family
ID=63472616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810506149.5A Pending CN108524667A (en) | 2018-05-23 | 2018-05-23 | It is a kind of that there is the lutein ester composition and preparation method thereof for alleviating visual fatigue effect |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108524667A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109601780A (en) * | 2018-11-01 | 2019-04-12 | 天津科技大学 | A kind of lycium ruthenicum anti-fatigue beverage and preparation method thereof |
| CN110292090A (en) * | 2019-08-14 | 2019-10-01 | 郑州福盛康眼科医疗技术有限公司 | A kind of blueberry lutein ester pressed candy and preparation method thereof |
| CN110338410A (en) * | 2019-08-14 | 2019-10-18 | 郑州福盛康眼科医疗技术有限公司 | A kind of eye health protection product and preparation method thereof |
| CN111214640A (en) * | 2020-04-01 | 2020-06-02 | 梭医生物科技(上海)股份有限公司 | Leaf yellow Chinese wolfberry tablet capable of rapidly improving eyesight and preparation method thereof |
| CN111990524A (en) * | 2020-05-25 | 2020-11-27 | 河南磐康健康管理股份有限公司 | Composition for preventing and improving visual fatigue and preparation method thereof |
| CN112544840A (en) * | 2020-12-01 | 2021-03-26 | 严雨坤 | Preparation method of plant beverage for relieving visual fatigue |
| CN113287698A (en) * | 2021-04-16 | 2021-08-24 | 上海信仁医药研究所 | Formula and preparation method of eye-protecting beverage |
| CN114681566A (en) * | 2020-12-31 | 2022-07-01 | 北京中医药大学 | Composition for protecting eyesight of teenagers and preparation method thereof |
| CN114681533A (en) * | 2020-12-31 | 2022-07-01 | 北京中医药大学 | Composition for protecting eyesight of teenagers and preparation method thereof |
| CN116889597A (en) * | 2023-08-23 | 2023-10-17 | 首曜(江苏)生物科技有限公司 | Composition for relieving asthenopia and improving eyesight and preparation method thereof |
| WO2024055795A1 (en) * | 2022-09-16 | 2024-03-21 | 大连工业大学 | Medicine and food dual-purpose composition capable of resisting blue light damage to retina, preparation method therefor, and use thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103053746A (en) * | 2012-12-28 | 2013-04-24 | 崇左市江州区生产力促进中心 | Vision-improving tea and production method thereof |
| CN105105244A (en) * | 2015-09-22 | 2015-12-02 | 哈尔滨宝德生物技术股份有限公司 | Lutein drink with effect of relieving visual fatigue and preparation method thereof |
| JP2016074643A (en) * | 2014-10-08 | 2016-05-12 | 株式会社えがお | Processed foods containing tagetes extract |
| CN106236739A (en) * | 2016-07-27 | 2016-12-21 | 上海宣泰生物科技有限公司 | Compositions containing phylloxanthin/lutein ester and application thereof |
| CN107213271A (en) * | 2017-05-31 | 2017-09-29 | 江苏朸健生命科技发展有限公司 | One kind alleviates asthenopia tablet and preparation method thereof |
| CN107375505A (en) * | 2017-08-15 | 2017-11-24 | 庞会心 | A kind of composition for preventing and treating eye disease and preparation method and application |
-
2018
- 2018-05-23 CN CN201810506149.5A patent/CN108524667A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103053746A (en) * | 2012-12-28 | 2013-04-24 | 崇左市江州区生产力促进中心 | Vision-improving tea and production method thereof |
| JP2016074643A (en) * | 2014-10-08 | 2016-05-12 | 株式会社えがお | Processed foods containing tagetes extract |
| CN105105244A (en) * | 2015-09-22 | 2015-12-02 | 哈尔滨宝德生物技术股份有限公司 | Lutein drink with effect of relieving visual fatigue and preparation method thereof |
| CN106236739A (en) * | 2016-07-27 | 2016-12-21 | 上海宣泰生物科技有限公司 | Compositions containing phylloxanthin/lutein ester and application thereof |
| CN107213271A (en) * | 2017-05-31 | 2017-09-29 | 江苏朸健生命科技发展有限公司 | One kind alleviates asthenopia tablet and preparation method thereof |
| CN107375505A (en) * | 2017-08-15 | 2017-11-24 | 庞会心 | A kind of composition for preventing and treating eye disease and preparation method and application |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109601780A (en) * | 2018-11-01 | 2019-04-12 | 天津科技大学 | A kind of lycium ruthenicum anti-fatigue beverage and preparation method thereof |
| CN110292090A (en) * | 2019-08-14 | 2019-10-01 | 郑州福盛康眼科医疗技术有限公司 | A kind of blueberry lutein ester pressed candy and preparation method thereof |
| CN110338410A (en) * | 2019-08-14 | 2019-10-18 | 郑州福盛康眼科医疗技术有限公司 | A kind of eye health protection product and preparation method thereof |
| CN111214640A (en) * | 2020-04-01 | 2020-06-02 | 梭医生物科技(上海)股份有限公司 | Leaf yellow Chinese wolfberry tablet capable of rapidly improving eyesight and preparation method thereof |
| CN111990524A (en) * | 2020-05-25 | 2020-11-27 | 河南磐康健康管理股份有限公司 | Composition for preventing and improving visual fatigue and preparation method thereof |
| CN112544840A (en) * | 2020-12-01 | 2021-03-26 | 严雨坤 | Preparation method of plant beverage for relieving visual fatigue |
| CN114681566A (en) * | 2020-12-31 | 2022-07-01 | 北京中医药大学 | Composition for protecting eyesight of teenagers and preparation method thereof |
| CN114681533A (en) * | 2020-12-31 | 2022-07-01 | 北京中医药大学 | Composition for protecting eyesight of teenagers and preparation method thereof |
| CN113287698A (en) * | 2021-04-16 | 2021-08-24 | 上海信仁医药研究所 | Formula and preparation method of eye-protecting beverage |
| WO2024055795A1 (en) * | 2022-09-16 | 2024-03-21 | 大连工业大学 | Medicine and food dual-purpose composition capable of resisting blue light damage to retina, preparation method therefor, and use thereof |
| CN116889597A (en) * | 2023-08-23 | 2023-10-17 | 首曜(江苏)生物科技有限公司 | Composition for relieving asthenopia and improving eyesight and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108524667A (en) | It is a kind of that there is the lutein ester composition and preparation method thereof for alleviating visual fatigue effect | |
| CN104856035A (en) | Health-care product for recuperating specific intrinsic constitution | |
| CN101248878A (en) | Health food and its preparation of nutrition second nerve | |
| CN104351795A (en) | Meal replacement powder for assisting blood pressure lowering and preparation method of meal replacement powder for assisting blood pressure lowering | |
| CN104256617B (en) | A kind of have the food of improving eyesight effect, health product or pharmaceutical composition | |
| JP6463504B2 (en) | Health supplements for hair growth promotion, hair loss relief and improvement, blood sugar control, gastrointestinal symptom relief and improvement | |
| CN109430856A (en) | A kind of eye-protecting improves the Ricipe for health care food and preparation method thereof of visual fatigue | |
| CN109588452A (en) | Safe and reliable nutrition-balanced nourishing class vegetables vegetarian diet is dry and preparation method thereof for refreshment | |
| CN106106680B (en) | A kind of production method of dendrobium nobile moon cake | |
| CN102100275B (en) | Cassia seed tea | |
| CN103462020A (en) | Natural nutrient capable of inhibiting harm of heavy metal and pesticide residue | |
| CN103478560B (en) | Nutrition rice prepared through milk and gynostemma pentaphylla | |
| KR101186508B1 (en) | Manufacturing method of healthy food using germinated grain | |
| CN104798950A (en) | Immune kungfu tea and preparation method thereof | |
| KR102163202B1 (en) | A method of producing a pill for relieve hangovers and the pill for relieve hangovers using the same as | |
| KR20030053417A (en) | Health food composition which contains Saururus chinensis Baill. and others | |
| CN107183597A (en) | A kind of indigo fruit functional food | |
| CN106072631A (en) | A kind of compositions alleviating asthenopia, spot-eliminating beauty treatment and its preparation method and application | |
| CN108112869A (en) | A kind of bitter buckwheat to relax bowel is gone with rice or bread solid granules and preparation method thereof | |
| CN108159191B (en) | Composition for tonifying yang and invigorating kidney, application and oral liquid and preparation method thereof | |
| CN109619479A (en) | A kind of haw products and preparation method thereof with alleviation visual fatigue | |
| CN108524794A (en) | One kind can prevent three height and the raised four drops tea of uric acid and preparation method thereof | |
| CN110226721A (en) | A kind of composition with auxiliary hyperglycemic function | |
| KR102515041B1 (en) | Health food using sprout ginseng and manufacturing method of the same | |
| CN109123674A (en) | A kind of black fruit fructus lycii compound alleviation visual fatigue piece and its preparation process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180914 |
|
| RJ01 | Rejection of invention patent application after publication |